Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors.

PHASE3RecruitingINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

May 1, 2025

Study Completion Date

May 31, 2025

Conditions

Luteinised Follicular Cyst

Interventions

DRUG

Administration of letrozole

Oral administration of letrozole 5 mg (each capsule is 2.5 mg) once a day for 5 days starting on the night of the follicular puncture.

Trial Locations (1)

RECRUITING

IVI-Madrid, Madrid

All Listed Sponsors

lead

IVI Madrid

OTHER